HO2 — DR Horton Cashflow Statement
0.000.00%
- €33.67bn
- €37.70bn
- $36.80bn
Annual cashflow statement for DR Horton, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 2,381 | 4,191 | 5,896 | 4,795 | 4,806 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 51.6 | 131 | 176 | 192 | 197 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -1,105 | -3,852 | -5,620 | -728 | -2,919 |
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Payable / Accrued Expenses | |||||
Cash from Operating Activities | 1,422 | 534 | 562 | 4,304 | 2,190 |
Capital Expenditures | -287 | -267 | -148 | -149 | -165 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 121 | 15.2 | -267 | -162 | -25.3 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -166 | -252 | -415 | -310 | -191 |
Financing Cash Flow Items | -43.3 | -80.9 | 29.4 | -111 | -108 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 271 | -85.1 | -811 | -2,667 | -1,355 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 1,526 | 197 | -664 | 1,327 | 644 |